These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 12833900)
1. Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism. Horng S; Grady C IRB; 2003; 25(1):11-6. PubMed ID: 12833900 [No Abstract] [Full Text] [Related]
2. Therapeutic misconception in early phase gene transfer trials. Henderson GE; Easter MM; Zimmer C; King NM; Davis AM; Rothschild BB; Churchill LR; Wilfond BS; Nelson DK Soc Sci Med; 2006 Jan; 62(1):239-53. PubMed ID: 16000230 [TBL] [Abstract][Full Text] [Related]
3. Beyond informed consent: the therapeutic misconception and trust. de Melo-MartÃn I; Ho A J Med Ethics; 2008 Mar; 34(3):202-5. PubMed ID: 18316464 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis. Kimmelman J; Palmour N J Med Ethics; 2005 Apr; 31(4):209-14. PubMed ID: 15800361 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic misconception in clinical research: frequency and risk factors. Appelbaum PS; Lidz CW; Grisso T IRB; 2004; 26(2):1-8. PubMed ID: 15069970 [No Abstract] [Full Text] [Related]
6. Phase 1 oncology trials and informed consent. Miller FG; Joffe S J Med Ethics; 2013 Dec; 39(12):761-4. PubMed ID: 23161617 [TBL] [Abstract][Full Text] [Related]
7. Consent forms and the therapeutic misconception: the example of gene transfer research. King NM; Henderson GE; Churchill LR; Davis AM; Hull SC; Nelson DK; Parham-Vetter PC; Rothschild BB; Easter MM; Wilfond BS IRB; 2005; 27(1):1-8. PubMed ID: 15835063 [No Abstract] [Full Text] [Related]
8. Randomization and the transactional framework for informed consent. Reynolds D; Fleming DA Am J Bioeth; 2009 Feb; 9(2):16-7. PubMed ID: 19180385 [No Abstract] [Full Text] [Related]
9. Understanding informed consent for participation in international health research. Jegede AS Dev World Bioeth; 2009 Aug; 9(2):81-7. PubMed ID: 18637943 [TBL] [Abstract][Full Text] [Related]
11. Randomization can be risky. Lott J Am J Bioeth; 2009 Feb; 9(2):17-8. PubMed ID: 19180386 [No Abstract] [Full Text] [Related]
12. The problem with optimism in clinical trials. Jansen LA IRB; 2006; 28(4):13-9. PubMed ID: 17036434 [No Abstract] [Full Text] [Related]
13. Phase I cancer trials. A collusion of misunderstanding. Miller M Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892 [No Abstract] [Full Text] [Related]
15. Twenty-five years of therapeutic misconception. Miller FG Hastings Cent Rep; 2008; 38(2):6; author reply 6-7. PubMed ID: 18457218 [No Abstract] [Full Text] [Related]
16. Clarifying the ethics of clinical research: a path toward avoiding the therapeutic misconception. Appelbaum PS Am J Bioeth; 2002; 2(2):22-3. PubMed ID: 12189066 [No Abstract] [Full Text] [Related]
17. Equipoise may be in the eye of the beholder. Moyer A; Floyd AH Am J Bioeth; 2009 Feb; 9(2):21-2. PubMed ID: 19180388 [No Abstract] [Full Text] [Related]
18. Patients versus surrogates: whose opinion counts on ethics review panels? Llewellyn-Thomas HA; Thiel EC; Clark RM Clin Res; 1989 Sep; 37(3):501-5. PubMed ID: 2776397 [No Abstract] [Full Text] [Related]
19. The therapeutic misconception, beneficence, and respect. Fried E Account Res; 2001; 8(4):331-48. PubMed ID: 12481794 [TBL] [Abstract][Full Text] [Related]